Back
BioXcel Therapeutics Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23
BTAI
BioXcel Therapeutics
Last Price:
$1.37
Seasonality Move:
-13.11%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.BioXcel Therapeutics Stock Forecast
-
Is BioXcel Therapeutics Stock Undervalued?The current BioXcel Therapeutics [BTAI] share price is $1.43. The Score for BTAI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will BioXcel Therapeutics Stock Go Up Next Year?
Data Unavailable
BioXcel Therapeutics Stock Rating
Data Unavailable
BioXcel Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bioxceltherapeutics.com
52-Week Data
52-Week High:
36.64
52-Week Low:
1.29
Prediction Charts
Market Cap:
7.8M
Price in USD:
1.43
Volume:
229.8K
Beta:
0.73
Technical Analysis
SMA50:
2.01
SMA100:
3.34
SMA200:
6.67
52-Wk Change:
-95.91%
Stock Predictions
-
Is BioXcel Therapeutics stock public?Yes, BioXcel Therapeutics is a publicly traded company.
-
What is the BioXcel Therapeutics stock quote today?The BioXcel Therapeutics stock price is 1.43 USD today.
-
How to buy BioXcel Therapeutics stock online?You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 1.75 | 1.85 | 1.88 | 1.73 |
| Apr-25 | 1.80 | 1.87 | 1.91 | 1.80 |
| Apr-28 | 1.90 | 1.96 | 1.98 | 1.87 |
| Apr-29 | 1.91 | 1.99 | 2.09 | 1.91 |
| Apr-30 | 1.98 | 1.85 | 1.98 | 1.78 |
| May-1 | 1.90 | 1.78 | 1.95 | 1.75 |
| May-2 | 1.84 | 1.78 | 1.89 | 1.74 |
| May-5 | 1.79 | 1.71 | 1.82 | 1.67 |
| May-6 | 1.71 | 1.58 | 1.75 | 1.56 |
| May-7 | 1.57 | 1.53 | 1.61 | 1.50 |
| May-8 | 1.52 | 1.58 | 1.60 | 1.50 |
| May-9 | 1.60 | 1.53 | 1.64 | 1.50 |
| May-12 | 1.59 | 1.48 | 1.59 | 1.43 |
| May-13 | 1.48 | 1.43 | 1.51 | 1.35 |
BioXcel Therapeutics Earnings
Data Unavailable
BioXcel Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.65 per share, and a decrease next year of $7.26 per share.
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.